A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic

Alberto Zaniboni, Michele Ghidini, Francesco Grossi, Alice Indini, Francesca Trevisan, Alessandro Iaculli, Lorenzo Dottorini, Giovanna Moleri, Alessandro Russo, Ivano Vavassori, Alessandra Brevi, Emanuele Rausa, Luigi Boni, Daniele Dondossola, Nicola Valeri, Antonio Ghidini, Gianluca Tomasello, Fausto Petrelli, Alberto Zaniboni, Michele Ghidini, Francesco Grossi, Alice Indini, Francesca Trevisan, Alessandro Iaculli, Lorenzo Dottorini, Giovanna Moleri, Alessandro Russo, Ivano Vavassori, Alessandra Brevi, Emanuele Rausa, Luigi Boni, Daniele Dondossola, Nicola Valeri, Antonio Ghidini, Gianluca Tomasello, Fausto Petrelli

Abstract

The COVID-19 pandemic has inevitably caused those involved in cancer care to change clinical practice in order to minimize the risk of infection while maintaining cancer treatment as a priority. General advice during the pandemic suggests that most patients continue with ongoing therapies or planned surgeries, while follow-up visits may instead be delayed until the resolution of the outbreak. We conducted a literature search using PubMed to identify articles published in English language that reported on care recommendations for cancer patients during the COVID-19 pandemic from its inception up to 1st June 2020, using the terms "(cancer or tumor) AND (COVID 19)". Articles were selected for relevance and split into five categories: (1) personal recommendations of single or multiple authors, (2) recommendations of single authoritative centers, (3) recommendations of panels of experts or of multiple regional comprehensive centers, (4) recommendations of multicenter cooperative groups, (5) official guidelines or recommendations of health authorities. Of the 97 included studies, 10 were personal recommendations of single or multiple independent authors, 16 were practice recommendations of single authoritative cancer centers, 35 were recommendations provided by panel of experts or of multiple regional comprehensive centers, 19 were cooperative group position papers, and finally, 17 were official guidelines statements. The COVID-19 pandemic is a global emergency, and has rapidly modified our clinical practice. Delaying unnecessary treatment, minimizing toxicity, and identifying care priorities for surgery, radiotherapy, and systemic therapies must be viewed as basic priorities in the COVID-19 era.

Keywords: COVID-19; cancer; pandemic; patients; treatment.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of included studies.

References

    1. Lalani A.-K.A., Chi K.N., Heng D.Y., Kollmannsberger C.K., Sridhar S.S., Blais N., Canil C., Czaykowski P., Hotte S.J., Iqbal N., et al. Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Can. Urol. Assoc. J. 2020 doi: 10.5489/cuaj.6595.
    1. Salari A., Shirkhoda M. COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings. Oral Oncol. 2020;105:104693.
    1. Scotté F., Minvielle E., Mir O., André F., Barlesi F., Soria J.-C. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19-positive patients with cancer. Eur. J. Cancer. 2020;132:1–4. doi: 10.1016/j.ejca.2020.03.020.
    1. Schrag D., Hershman D.L., Basch E. Oncology practice during the COVID-19 pandemic. JAMA J. Am. Med. Assoc. 2020 doi: 10.1001/jama.2020.6236.
    1. Wang Z., Wang J., He J. Active and effective measures for the care of patients with cancer during the COVID-19 spread in China. JAMA Oncol. 2020 doi: 10.1001/jamaoncol.2020.1198.
    1. Qadan M., Hong T.S., Tanabe K.K., Ryan D.P., Lillemoe K.D. A multidisciplinary team approach for triage of elective cancer surgery at the massachusetts general hospital during the novel coronavirus COVID-19 outbreak. Ann. Surg. 2020 doi: 10.1097/SLA.0000000000003963.
    1. Di Saverio S., Pata F., Gallo G., Carrano F., Scorza A., Sileri P., Smart N., Spinelli A., Pellino G. Coronavirus pandemic and colorectal surgery: Practical advice based on the Italian experience. Color. Dis. 2020 doi: 10.1111/codi.15056.
    1. Cafarotti S., Patella M., Iosi L.C.C. Lung cancer surgical management during the outbreak of COVID-19. J. Thorac. Oncol. 2020 doi: 10.1016/j.jtho.2020.03.027.
    1. Kattan J., Kattan C., Assi T. Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? Immunotherapy. 2020:19–22. doi: 10.2217/imt-2020-0077.
    1. Zhao Z., Bai H., Duan J., Wang J. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. Thorac. Cancer. 2020 doi: 10.1111/1759-7714.13424.
    1. Banna G., Curioni-Fontecedro A., Friedlaender A., Addeo A. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: Primum non nocere. ESMO Open. 2020;5:e000765. doi: 10.1136/esmoopen-2020-000765.
    1. Braunstein L.Z., Gillespie E.F., Hong L., Xu A., Bakhoum S.F., Cuaron J., Mueller B., McCormick B., Cahlon O., Powell S., et al. Breast radiotherapy under COVID-19 pandemic resource constraints—Approaches to defer or shorten treatment from a comprehensive cancer center in the United States. Adv. Radiat Oncol. 2020 doi: 10.1016/j.adro.2020.03.013.
    1. Mandato V.D., Aguzzoli L. Management of ovarian cancer during the COVID-19 pandemic. Int. J. Gynaecol. Obstet. 2020:2–4. doi: 10.1002/ijgo.13167.
    1. Ansarin M. Surgical management of head and neck tumours during the SARS-CoV (Covid-19) pandemic. Acta Otorhinolaryngol Ital. 2020:1–3. doi: 10.14639/0392-100X-N0783.
    1. De Felice F., Polimeni A., Valentini V. The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care. Radiother. Oncol. 2020;147:84–85. doi: 10.1016/j.radonc.2020.03.020.
    1. Jazieh A.R., Al Hadab A., Al Olayan A., Alhejazi A., Al Safi F., Al Qarni A., Farooqui F., Al Mutairi N., Alenazi T.H. Managing oncology services during a major coronavirus outbreak: Lessons from the saudi arabia experience. JCO Glob. Oncol. 2020;6:518–524. doi: 10.1200/GO.20.00063.
    1. Motlagh A., Yamrali M., Azghandi S., Azadeh P., Vaezi M., Ashrafi F., Zendehdel K., Mirzaei H., Basi A., Rakhsha A., et al. COVID19 prevention & care; a cancer specific guideline. Arch. Iran. Med. 2020;23:255–264. doi: 10.34172/aim.2020.07.
    1. Shankar A., Saini D., Roy S., Jarrahi A.M., Chakraborty A., Bharti S.J., Taghizadeh-Hesary F. Cancer care delivery challenges amidst coronavirus disease -19 (covid-19) outbreak: Specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pacific. J. Cancer Prev. 2020;21:569–573. doi: 10.31557/APJCP.2020.21.3.569.
    1. Wang H., Wang S., Yu K. COVID-19 infection epidemic: The medical management strategies in Heilongjiang Province, China. Crit. Care. 2020;24:10–13. doi: 10.1186/s13054-020-2832-8.
    1. Pino L., Perez C., Cardona A., Triana I. Cancer center recommendations to mitigate covid-19 impact in patients with cancer: Low-resource settings version. JCO Glob. Oncol. 2020;6:569–570. doi: 10.1200/GO.20.00093.
    1. Kutikov A., Weinberg D.S., Edelman M.J., Horwitz E.M., Uzzo R.G., Fisher R.I. A war on two fronts: Cancer care in the time of COVID-19. Ann. Intern. Med. 2020;172:1–4. doi: 10.7326/M20-1133.
    1. Cinar P., Kubal T., Freifeld A., Mishra A., Shulman L., Bachman J., Fonseca R., Uronis H., Klemanski D., Slusser K., et al. Safety at the time of the COVID-19 pandemic: How to keep our oncology patients and healthcare workers safe. J. Natl. Compr. Canc. Netw. 2020;18:1–6. doi: 10.6004/jnccn.2020.7572.
    1. Lambertini M., Toss A., Passaro A., Criscitiello C., Cremolini C., Cardone C., Loupakis F., Viscardi G., Meattini I., Dieci M.V., et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists’ perspective. ESMO Open. 2020;5:e000759. doi: 10.1136/esmoopen-2020-000759.
    1. Soran A., Gimbel M., Diego E. Breast cancer diagnosis, treatment and follow-up during COVID-19 pandemic. Eur. J. Breast Heal. 2020;16:86–88. doi: 10.5152/ejbh.2020.240320.
    1. Çakmak G.K. Sars-CoV-2 (COVID-19) outbreak and breast cancer surgery in Turkey. Eur. J. Breast Health. 2020;16:83–85. doi: 10.5152/ejbh.2020.300320.
    1. Curigliano G., Cardoso M.J., Poortmans P., Gentilini O., Pravettoni G., Mazzocco K., Houssami N., Pagani O., Senkus E., Cardoso F., et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8–16. doi: 10.1016/j.breast.2020.04.006.
    1. Marijnen C., Peters F., Rödel C., Bujko K., Haustermans K., Fokas E., Glynne-Jones R., Valentini V., Spindler K.-L., Guren M., et al. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother. Oncol. 2020 doi: 10.1016/j.radonc.2020.03.039.
    1. Carneiro A., Wroclawski M.L., Nahar B., Soares A., Cardoso A.P., Kim N.J., Carvalho F.T. Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: A management guideline proposal for low- and middle-income countries during the crisis period. Int. Braz. J. Urol. 2020;46:1–10. doi: 10.1590/s1677-5538.ibju.2020.04.03.
    1. Ficarra V., Novara G., Abrate A., Bartoletti R., Crestani A., De Nunzio C., Giannarini G., Gregori A., Liguori G., Mirone V., et al. Urology practice during COVID-19 pandemic. Minerva. Urol. Nefrol. 2020 doi: 10.23736/S0393-2249.20.03846-1.
    1. Ramirez P.T., Chiva L., Eriksson A.G.Z., Frumovitz M., Fagotti A., Martin A.G., Jhingran A., Pareja R. COVID-19 global pandemic: Options for management of gynecologic cancers. Int. J. Gynecol. Cancer. 2020 doi: 10.1136/ijgc-2020-001419.
    1. Der Sarkissian S.A., Kim L., Veness M., Yiasemides E., Sebaratnam D.F. Recommendations on dermatologic surgery during the COVID-19 pandemic. J. Am. Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.04.034.
    1. Krengli M., Ferrara E., Mastroleo F., Brambilla M., Ricardi U. Running a radiation oncology department at the time of coronavirus: An Italian experience. Adv. Radiat. Oncol. 2020 doi: 10.1016/j.adro.2020.03.003.
    1. Meattini I., Franco P., Belgioia L., Boldrini L., Botticella A., De Santis M.C., Marvaso G., Montesi G., Parisi S., Triggiani L., et al. Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation’s young oncologists. ESMO Open. 2020;5:2019–2021. doi: 10.1136/esmoopen-2020-000779.
    1. Zaorsky N.G., Yu J.B., McBride S.M., Dess R.T., Jackson W.C., Mahal B.A., Chen R., Choudhury A., Henry A., Syndikus I., et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv. Radiat. Oncol. 2020 doi: 10.1016/j.adro.2020.03.010.
    1. Al-Shamsi H.O., Alhazzani W., Alhuraiji A., Coomes E.A., Chemaly R.F., Almuhanna M., Wolff R.A., Ibrahim N.K., Chua M.L., Hotte S.J., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international collaborative group. Oncologist. 2020;2019:1–10. doi: 10.1634/theoncologist.2020-0213.
    1. Thureau S., Faivre J.C., Assaker R., Biver E., Confavreux C.B., Debiais F., Duterque-Coquillaud M., Giammarile F., Heymann D., Lecouvet F.E., et al. Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper. J. Bone Oncol. 2020 doi: 10.1016/j.jbo.2020.100291.
    1. Penel N., Bonvalot S., Minard V., Orbach D., Gouin F., Corradini N., Brahmi M., Marec-Berard P., Briand S., Gaspar N., et al. French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak. Bull. Cancer. 2020 doi: 10.1016/j.annonc.2020.03.308.
    1. Thoracic Surgery Outcomes Research Network, Inc COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from thoracic surgery outcomes research network. Ann. Thorac. Surg. 2020 doi: 10.1016/j.athoracsur.2020.03.005.
    1. Akladios C., Azais H., Ballester M., Bendifallah S., Bolze P.-A., Bourdel N., Bricou A., Canlorbe G., Carcopino X., Chauvet P., et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic—FRANCOGYN group for the CNGOF. J. Gynecol. Obstet. Hum. Reprod. 2020:101729. doi: 10.1016/j.jogoh.2020.101729.
    1. Bartlett D.L., Oncology F.T.S.O.S., Howe J.R., Chang G., Crago A., Hogg M., Karakousis G., Levine E., Maker A., Mamounas E., et al. Management of cancer surgery cases during the COVID-19 pandemic: Considerations. Ann. Surg. Oncol. 2020;27:1–4. doi: 10.1245/s10434-020-08461-2.
    1. Bitar N., Kattan J., Kourie H.R., Mukherji D., el Saghir N. The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic. Future Oncol. 2020;16:615–617. doi: 10.2217/fon-2020-0252.
    1. Coles C., Aristei C., Bliss J., Boersma L., Brunt A., Chatterjee S., Hanna G., Jagsi R., Person O.K., Kirby A., et al. International guidelines on radiation therapy for breast cancer during the COVID-19 Pandemic. Clin. Oncol. 2020;32:279–281. doi: 10.1016/j.clon.2020.03.006.
    1. Fakhry N., Schultz P., Morinière S., Breuskin I., Bozec A., Vergez S., De Garbory L., Hartl D., Temam S., Lescanne E., et al. French consensus on management of head and neck cancer surgery during COVID-19 pandemic. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020:8–9. doi: 10.1016/j.anorl.2020.04.008.
    1. Kimmig R., Verheijen R.H.M., Rudnicki M. Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: A statement of the Society of European Robotic Gynaecological Surgery (SERGS) J. Gynecol. Oncol. 2020;31:1–7. doi: 10.3802/jgo.2020.31.e59.
    1. Thomson D.J., Palma D., Guckenberger M., Balermpas P., Beitler J.J., Blanchard P., Brizel D., Budach W., Caudell J., Corry J., et al. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Int. J. Radiat. Oncol. Biol. Phys. 2020;107:618–627. doi: 10.1016/j.ijrobp.2020.04.016.
    1. Yahalom J., Dabaja B.S., Ricardi U., Ng A., Mikhaeel N.G., Vogelius I.R., Illidge T., Qi S., Wirth A., Specht L. ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic. Blood. 2020 doi: 10.1182/blood.2020006028.
    1. You B., Ravaud A., Canivet A., Ganem G., Giraud P., Guimbaud R., Kaluzinski L., Krakowski I., Mayeur D., Grellety T., et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020;2045:20–21. doi: 10.1016/S1470-2045(20)30204-7.
    1. Mohile N., Blakeley O.J., Gatson N.T.N., Hottinger A.F., Lassman A.B., Ney E.D., Olar A., Schiff D., Shih A.H., Strowd R., et al. Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. Neuro Oncol. 2020 doi: 10.1093/neuonc/noaa090.
    1. Ribal M.J., Cornford P., Briganti A., Knoll T., Gravas S., Babjuk M., Harding C., Breda A., Bex A., Rassweiler J.J., et al. EAU section offices and the EAU guidelines panels. European association of urology guidelines office rapid reaction group: An organisation-wide collaborative effort to adapt the european association of urology guidelines recommendations to the coronavirus disease 2019. Era. Eur. Urol. 2020;78:21–28. doi: 10.1016/j.eururo.2020.04.056.
    1. Von Lilienfeld-Toal M., Vehreschild J.J., Cornely O., Pagano L., Compagno F., Hirsch H.H., Pagliuca A. EHA Infectious Disease Scientific Working Group. Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia. 2020 doi: 10.1038/s41375-020-0832-y.
    1. Chan A., Ashbury F., Fitch M.I., Koczwara B., Chan R.J., MASCC Survivorship Study Group Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group. Support Care Cancer. 2020;28:3485–3488. doi: 10.1007/s00520-020-05544-4.
    1. Ueda M., Martins R., Hendrie P.C., McDonnell T., Crews J.R., Wong T.L., McCreery B., Jagels B., Crane A., Byrd D.R., et al. Managing cancer care during the COVID-19 pandemic: Agility and collaboration toward a common goal. J. Natl. Compr. Canc. Netw. 2020;18:1–4. doi: 10.6004/jnccn.2020.7560.
    1. Kowalski L.P., Sanabria A., Ridge J.A., Ng W.T., De Bree R., Rinaldo A., Takes R.P., Mäkitie A.A., Carvalho A.L., Bradford C.R., et al. COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck. 2020 doi: 10.1002/hed.26164.
    1. Ma C.H.M.S., Vukkadala N., Tsang R.K.Y., Sunwoo J.B., Holsinger F.C., Chan J.Y.K., Damrose E.J., Kearney A., Starmer H.M. Managing head and neck cancer patients with tracheostomy or laryngectomy during the COVID-19 pandemic. Head Neck. 2020;42:1209–1219. doi: 10.1002/hed.26171.
    1. Liu Z., Zhang Y., Wang X., Zhang D., Diao D., Chandramohan K., Booth C.M. Recommendations for surgery during the novel coronavirus (COVID-19) epidemic. Indian J. Surg. 2020:1–5. doi: 10.1007/s12262-020-02173-3.
    1. Ardura M., Hartley D., Dandoy C., Lehmann L., Jaglowski S., Auletta J.J. Transplant-Associated Learning Network Team (TALNT). Addressing the impact of the Coronavirus Disease 2019 (COVID-19) pandemic on hematopoietic cell transplantation: Learning networks as a means for sharing best practices. Biol. Blood Marrow Transpl. 2020 doi: 10.1016/j.bbmt.2020.04.018.
    1. Davis A.P., Boyer M., Lee J.H., Kao S. COVID-19: The use of immunotherapy in metastatic lung cancer. Immunotherapy. 2020 doi: 10.2217/imt-2020-0096.
    1. Dietz J.R., Moran M.S., Isakoff S.J., Kurtzman S.H., Willey S.C., Burstein H.J., Bleicher R.J., Lyons J.A., Sarantou T., Baron P.L., et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res. Treat. 2020 doi: 10.1007/s10549-020-05644-z.
    1. Finley C., Prashad A., Camuso N., Daly C., Aprikian A., Ball C.G., Bentley J., Charest D., Fata P., Helyer L., et al. Guidance for management of cancer surgery during the COVID-19 pandemic. Can. J. Surg. 2020;63:S2–S4. doi: 10.1503/cjs.005620.
    1. Gentileschi S., Caretto A.A., Tagliaferri L., Salgarello M., Peris K. Skin cancer plastic surgery during the COVID-19 pandemic. Eur. J. Surg. Oncol. 2020 doi: 10.1016/j.ejso.2020.04.048.
    1. Glehen O., Kepenekian V., Bouché O., Gladieff L., Honore C., Abba J., Abboud K., Arvieux C., Bakrin N., Delhorme J.-B., et al. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. J. Visc. Surg. 2020 doi: 10.1016/j.jviscsurg.2020.04.013.
    1. Maniakas A., Jozaghi Y., Zafereo M.E., Sturgis E.M., Su S.Y., Gillenwater A.M., Gidley P.W., Lewis C.M., Diaz E., MD Anderson Head and Neck Surgery Treatment Guidelines Consortium et al. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 doi: 10.1002/hed.26206.
    1. Koffman B., Mato A.R., Byrd J.C., Danilov A., Hedrick B., Ujjani C., Roeker L., Stephens D.M., Davids M.S., Pagel J.M., et al. Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts. Am. J. Hematol. 2020 doi: 10.1002/ajh.25851.
    1. Lou E., Beg S., Bergsland E., Eng C., Khorana A., Kopetz S., Lubner S., Saltz L., Shankaran V., Zafar S.Y. Modifying practices in GI oncology in the face of COVID-19: Recommendations from expert oncologists on minimizing patient risk. JCO Oncol. Pract. 2020 doi: 10.1200/OP.20.00239.
    1. Monk B.J., Coleman R.L., Moore K.N., Herzog T.J., Secord A.A., Matulonis U.A., Slomovitz B.M., Guntupalli S.R., O’Malley D.M. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol. Oncol. 2020 doi: 10.1016/j.ygyno.2020.04.703.
    1. O’Cathail S., Gilbert D., Sebag-Montefiore D., Muirhead R. Challenges and consequences of COVID-19 in the management of anorectal cancer: Coming together through social distancing. Clin. Oncol. 2020 doi: 10.1016/j.clon.2020.04.009.
    1. Patnaik M., Lasho T., Padron E., McCullough K., Al-Kali A., Tefferi A., Zeidan A.M., Gangat N., Savona M., Steensma D.P., et al. Special considerations in the management of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic. Am. J. Hematol. 2020 doi: 10.1002/ajh.25853.
    1. Pothuri B., Secord A.A., Armstrong D.K., Chan J., Fader A.N., Huh W., Kesterson J., Liu J.F., Moore K., Westin S.N., et al. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol. Oncol. 2020 doi: 10.1016/j.ygyno.2020.04.694.
    1. Tagliaferri L., Di Stefani A., Schinzari G., Fionda B., Rossi E., Del Regno L., Gentileschi S., Federico F., Valentini V., Tortora G. Skin cancer triage and management during COVID-19 pandemic. J. Eur. Acad. Dermatol. Venereol. 2020 doi: 10.1111/jdv.16529.
    1. Tasoulis M.K., Roche N., MacNeill F. Rationalizing breast cancer surgery during the COVID-19 pandemic. Eur. J. Surg. Oncol. 2020 doi: 10.1016/j.ejso.2020.04.049.
    1. Teoh J.Y.C., Roupret M., Shariat S.F., Herrmann T. Intravesical therapy for bladder cancer in the pandemic of Covid-19. World J. Urol. 2020 doi: 10.1007/s00345-020-03218-8.
    1. Troost E.G., Nestle U., Putora P.M., Bussink J. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother. Oncol. 2020 doi: 10.1016/j.radonc.2020.04.030.
    1. Werner M.T., Carey R.M., Albergotti W.G., Lukens J.N., Brody R.M. Impact of the COVID-19 pandemic on the management of head and neck malignancies. Otolaryngol. Head Neck Surg. 2020 doi: 10.1177/0194599820921413.
    1. Wu V., Noel C.W., Forner D., Zhang Z., Higgins K.M., Enepekides D.J., Lee J.M., Witterick I.J., Kim J.J., Waldron J.N., et al. Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experience. Head Neck. 2020 doi: 10.1002/hed.26205.
    1. Bergsland E.K., Halperin D.M., Dillon J.S., Dasari N.A., Kunz P.L., Soares H.P., Pryma D., Bodei L., Hope T., Soulen M.C., et al. North American neuroendocrine tumor society guide for neuroendocrine tumor patient health care providers during COVID-19. Pancreas. 2020;49:723–728. doi: 10.1097/MPA.0000000000001561.
    1. Terpos E., Engelhardt M., Cook G., Gay F., Mateos M.V., Ntanasis-Stathopoulos I., van de Donk N.W.C.J., Avet-Loiseau H., Hajek R., Vangsted A.J., et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: A consensus paper from the European Myeloma Network (EMN) Leukemia. 2020;22:1–12. doi: 10.1038/s41375-020-0876-z.
    1. Thompson C.K., Lee M.K., Baker J.L., Attai D.J., DiNome M.L. Taking a second look at neoadjuvant endocrine therapy for the treatment of early stage estrogen receptor positive breast cancer during the COVID-19 outbreak. Ann. Surg. 2020 doi: 10.1097/SLA.0000000000004027.
    1. Nguyen N.P., Vinh-Hung V., Baumert B.G., Zamagni A., Arenas M., Motta M., Lara P.C., Myint A.S., Bonet M., Popescu T., et al. Older cancer patients during the COVID-19 epidemic: Practice proposal of the international geriatric radiotherapy group. Cancers. 2020;12:1287. doi: 10.3390/cancers12051287.
    1. Li W.-M., Wang D., Guo J., Yuan G., Yang Z., Gale R.P., You Y., Chen Z., Chen S., Hubei Anti-Cancer Association et al. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34:1799–1804. doi: 10.1038/s41375-020-0853-6.
    1. Whisenant J.G., Trama A., Torri V., de Toma A., Viscardi G., Cortellini A., Micheilin O., Barlesi F., Dingemans A.-M.C., van Meerbeeck J., et al. TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer Cell. 2020;37:742–745. doi: 10.1016/j.ccell.2020.05.008.
    1. Sharma R., Pinato D.J. Management of hepatocellular cancer in the time of SARS-CoV-2. Liver Int. 2020 doi: 10.1111/liv.14517.
    1. Dingemans A.-M.C., Soo R.A., Jazieh A.R., Rice S.J., Kim Y.T., Teo L.L., Warren G.W., Xiao S.-Y., Smit E.F., Aerts J.G., et al. Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic. J. Thorac. Oncol. 2020;15:1119–1136. doi: 10.1016/j.jtho.2020.05.001.
    1. Viale G., Licata L., Sica L., Zambelli S., Zucchinelli P., Rognone A., Aldrighetti D., Di Micco R., Zuber V., Pasetti M., et al. Personalized risk-benefit ratio adaptation of breast cancer care at the epicenter of COVID-19 outbreak. Oncologist. 2020 doi: 10.1634/theoncologist.2020-0316.
    1. Di Fiore F., Thésaurus National de Cancérologie Digestive (TNCD) Société Nationale Française de Gastroentérologie (SNFGE) Fédération Francophone de Cancérologie Digestive (FFCD) Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR) Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) Société Française de Chirurgie Digestive (SFCD) Société Française d’Endoscopie Digestive (SFED) Société Française de Radiothérapie Oncologique (SFRO) and Société Française de Radiologie (SFR) Association Chirurgie Hepato-Biliaire et Transplantation (ACHBT) et al. COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) Dig. Liver Dis. 2020;52:597–603. doi: 10.1016/j.dld.2020.03.031.
    1. Hungria V., Garnica M., Crusoé E.D.Q., Filho R.J.P.D.M., Martinez G., Bittencourt R., de Farias D.L.C., Braga W.M., Neto J.V.P., Ribeiro G.N., et al. Managing patients with multiple myeloma during the COVID-19 pandemic: Recommendations from an expert panel—ABHH monoclonal gammopathies committe. Hematol. Transfus. Cell Ther. 2020 doi: 10.1016/j.htct.2020.05.001.
    1. Desideri I., Pilleron S., Battisti N.M.L., Gomes F., De Glas N., Neuendorff N.R., Liposits G., Paredero-Pérez I., Lok W.C.W., Loh K.P., et al. Caring for older patients with cancer during the COVID-19 pandemic: A young international society of geriatric oncology (SIOG) global perspective. J. Geriatr. Oncol. 2020 doi: 10.1016/j.jgo.2020.05.001.
    1. Geskin L.J., Trager M.H., Aasi S.Z., Bickers D.R., Carvajal R.D., Nghiem P., Taback B., Zeitouni N.C., Samie F.H. Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic. J. Am. Acad. Dermatol. 2020;83:295–296. doi: 10.1016/j.jaad.2020.05.002.
    1. Valenza F., Papagni G., Marchianò A., Daidone M.G., De’Braud F., Colombo M.P., Frignani A., Galmozzi G., Ladisa V., Pruneri G., et al. Response of a comprehensive cancer center to the COVID-19 pandemic: The experience of the fondazione IRCCS-istituto nazionale dei tumori di milano. Tumori. 2020 doi: 10.1177/0300891620923790.
    1. Vecchione L., Stintzing S., Pentheroudakis G., Douillard J.-Y., Lordick F. ESMO management and treatment adapted recommendations in the COVID-19 era: Colorectal cancer. ESMO Open. 2020;5(Suppl. 3):e000826. doi: 10.1136/esmoopen-2020-000826.
    1. Spolverato G., Capelli G., Restivo A., Bao Q.R., Pucciarelli S., Pawlik T.M., Gronchi A. The management of surgical patients during the coronavirus disease 2019 (COVID-19) pandemic. Surgery. 2020;168:4–10. doi: 10.1016/j.surg.2020.04.036.
    1. De Azambuja E., Trapani D., Loibl S., Delaloge S., Senkus E., Criscitiello C., Poortman P., Gnant M., di Cosimo S., Cortes J., et al. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer. ESMO Open. 2020;5(Suppl. 3):e000793. doi: 10.1136/esmoopen-2020-000793.
    1. Catanese S., Pentheroudakis G., Douillard J.Y., Lordick F. ESMO management and treatment adapted recommendations in the COVID-19 era: Pancreatic cancer. ESMO Open. 2020;5(Suppl. 3):e000804. doi: 10.1136/esmoopen-2020-000804.
    1. Jozaghi Y., Zafereo M.E., Perrier N.D., Wang J.R., Grubbs E., Gross N.D., Fisher S., Sturgis E.M., Goepfert R.P., Lai S.Y., et al. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical triage guidelines. Head Neck. 2020;42:1325–1328. doi: 10.1002/hed.26169.
    1. Jereczek-Fossa B.A., Palazzi M.F., Soatti C.P., Cazzaniga L.F., Ivaldi G.B., Pepa M., Amadori M., Antognoni P., Arcangeli S., CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) Network COVID-19 outbreak and cancer radiotherapy disruption in lombardy, Northern Italy. Clin. Oncol. 2020;32:e160–e161. doi: 10.1016/j.clon.2020.04.007.
    1. Van de Haar J., Hoes L.R., Coles C.E., Seamon K., Fröhling S., Jäger D., Valenza F., De Braud F., de Petris L., Bergh J., et al. Caring for patients with cancer in the COVID-19 era. Nat. Med. 2020;26:665–671. doi: 10.1038/s41591-020-0874-8.
    1. Yerramilli D., Xu A.J., Gillespie E.F., Shepherd A.F., Beal K., Gomez D., Yamada J., Tsai C.J., Yang T.J. Palliative radiotherapy for oncologic emergencies in the setting of COVID-19: Approaches to balancing risks and benefits. Adv. Radiat. Oncol. 2020 doi: 10.1016/j.adro.2020.04.001.
    1. Al-Rashdan A., Roumeliotis M., Quirk S., Grendarova P., Phan T., Cao J., Logie N., Smith W., Barbera L. Adapting radiation therapy treatments for patients with breast cancer during the COVID-19 pandemic: Hypo-fractionation and accelerated partial breast irradiation to address world health organization recommendations. Adv. Radiat. Oncol. 2020 doi: 10.1016/j.adro.2020.03.011.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit